Published in J Hosp Infect on May 01, 1994
Septic shock caused by Ochrobactrum anthropi in an otherwise healthy host. J Clin Microbiol (2003) 1.07
Ochrobactrum intermedium infection after liver transplantation. J Clin Microbiol (1999) 1.06
Bacteremia and respiratory involvement by Alcaligenes xylosoxidans in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis (1997) 1.04
Brucella outer membrane lipoproteins share antigenic determinants with bacteria of the family Rhizobiaceae. Clin Diagn Lab Immunol (1999) 0.96
Antibody and delayed-type hypersensitivity responses to Ochrobactrum anthropi cytosolic and outer membrane antigens in infections by smooth and rough Brucella spp. Clin Diagn Lab Immunol (1997) 0.95
PCR assay for diagnosis of human brucellosis. J Clin Microbiol (1999) 0.91
Comparative clinical study of different multiplex real time PCR strategies for the simultaneous differential diagnosis between extrapulmonary tuberculosis and focal complications of brucellosis. PLoS Negl Trop Dis (2013) 0.86
Clinical characteristics of Ochrobactrum anthropi bacteremia. J Clin Microbiol (2013) 0.83
Application of a polymerase chain reaction enzyme immunoassay in peripheral whole blood and serum specimens for diagnosis of acute human brucellosis. Eur J Clin Microbiol Infect Dis (2004) 0.80
Outbreak of Achromobacter xylosoxidans and Ochrobactrum anthropi Infections after Prostate Biopsies, France, 2014. Emerg Infect Dis (2016) 0.75
Ochrobactrum anthropi septic arthritis: case report and implications in orthopedic infections. Infect Dis Rep (2010) 0.75
Fluorescent whole-cell hybridization with 16S rRNA-targeted oligonucleotide probes to identify Brucella spp. by flow cytometry. J Clin Microbiol (2000) 0.75
Yersinia enterocolitica, a primary model for bacterial invasiveness. Rev Infect Dis (1987) 5.48
Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. J Clin Microbiol (1995) 4.44
Serogrouping of Clostridium difficile strains by slide agglutination. J Clin Microbiol (1985) 3.06
Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect (1997) 2.95
Pyrazinamidase activity in Yersinia enterocolitica and related organisms. J Clin Microbiol (1985) 2.83
[Supplement to the antigenic schema of Yersinia enterocolitica]. Ann Inst Pasteur (Paris) (1972) 2.52
Immunohistochemical localization and bacteriostatic properties of an iron-binding protein from bronchial mucus. Thorax (1966) 2.42
Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med (1999) 2.33
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation (1999) 2.27
Yersinia enterocolitica infections and pork: the missing link. Lancet (1987) 2.15
Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis (1999) 2.05
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation (1997) 1.90
Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrob Agents Chemother (1994) 1.89
[Somatic and flagellar antigens of Yersinia enterocolitica]. Ann Inst Pasteur (Paris) (1971) 1.82
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nocardia species. J Clin Microbiol (2010) 1.69
Nucleotide sequence of yst, the Yersinia enterocolitica gene encoding the heat-stable enterotoxin, and prevalence of the gene among pathogenic and nonpathogenic yersiniae. Infect Immun (1990) 1.68
Classification of Ralstonia pickettii biovar 3/'thomasii' strains (Pickett 1994) and of new isolates related to nosocomial recurrent meningitis as Ralstonia mannitolytica sp. nov. Int J Syst Evol Microbiol (2001) 1.67
IMx tacrolimus II vs IMx tacrolimus microparticle enzyme immunoassay evaluated in renal and hepatic transplant patients. Clin Chem (1997) 1.67
Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. Clin Microbiol Infect (2006) 1.65
Nonvalue of cold enrichment of stools for isolation of Yersinia enterocolitica serotypes 3 and 9 from patients. J Clin Microbiol (1980) 1.54
Safe preservation of human renal cadaver transplants by Euro-Collins solution up to 50 hours. Transplant Proc (1981) 1.50
Isolations of Leclercia adecarboxylata from a patient with a chronically inflamed gallbladder and from a patient with sepsis without focus. J Clin Microbiol (2001) 1.44
A meta-analysis dealing with the effectiveness of chlorhexidine and silver-sufhadiazine impregnated central venous catheters. J Hosp Infect (1998) 1.44
The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clin Pharmacol Ther (1998) 1.42
A simple adult-mouse test for tissue invasiveness in Yersinia enterocolitica strains of low experimental virulence. J Med Microbiol (1985) 1.41
The organization of infection control in Belgium. J Hosp Infect (2001) 1.39
Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int (1994) 1.38
Technetium-99m L,L-ethylenedicysteine clearance and correlation with iodine-125 orthoiodohippurate for the determination of effective renal plasma flow. Eur J Nucl Med (1996) 1.37
[A simple method for detecting glutamic acid decarboxylase in gram negative bacteria (author's transl)]. Ann Microbiol (Paris) (1975) 1.36
Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc (1987) 1.35
Isolation of Arthrobacter spp. from clinical specimens and description of Arthrobacter cumminsii sp. nov. and Arthrobacter woluwensis sp. nov. J Clin Microbiol (1996) 1.33
First aid for obstetric haemorrhage: the pilot study of the non-pneumatic anti-shock garment in Egypt. BJOG (2006) 1.33
Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation (2000) 1.33
Yersinia enterocolitica: its isolation by cold enrichment from patients and healthy subjects. J Clin Pathol (1981) 1.31
Rapid and specific molecular identification of methicillin-resistant Staphylococcus aureus in endotracheal aspirates from mechanically ventilated patients. J Clin Microbiol (1998) 1.30
Carriage of Yersinia enterocolitica serotype 3 by pigs as a source of human infection. Contrib Microbiol Immunol (1979) 1.27
Semisolid selective-motility enrichment medium for isolation of salmonellae from fecal specimens. J Clin Microbiol (1984) 1.23
Capsular typing of klebsiellae by coagglutination and latex agglutination. J Clin Microbiol (1981) 1.23
The association of gastric leptin with oesophageal inflammation and metaplasia. Gut (2007) 1.21
CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study. Am J Transplant (2006) 1.21
Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet (2002) 1.20
O:13a,13b, a new pathogenic serotype of Yersinia enterocolitica. J Clin Microbiol (1984) 1.19
Publication bias in abstracts presented to the annual meeting of the American Academy of Orthopaedic Surgeons. J Orthop Surg (Hong Kong) (2007) 1.16
Epidemiological investigation of a nosocomial outbreak of multidrug-resistant Corynebacterium striatum at one Belgian university hospital. Clin Microbiol Infect (2013) 1.15
Infections caused by Kingella kingae: report of four cases and review. J Infect (1986) 1.13
Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil. Ther Drug Monit (2003) 1.10
Prospective study of catalase-positive coryneform organisms in clinical specimens: identification, clinical relevance, and antibiotic susceptibility. Diagn Microbiol Infect Dis (1998) 1.09
Epidemiological and clinical aspects of human Yersinia enterocolitica infections in Belgium. Contrib Microbiol Immunol (1979) 1.08
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation (2001) 1.08
The expression of PEA-15 (phosphoprotein enriched in astrocytes of 15 kDa) defines subpopulations of astrocytes and neurons throughout the adult mouse brain. Neuroscience (2004) 1.08
Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis. Clin Nephrol (1997) 1.07
Pathogenicity of Yersinia kristensenii for mice. Infect Immun (1991) 1.07
Causative role of Yersinia and other enteric pathogens in the appendicular syndrome. Eur J Clin Microbiol Infect Dis (1991) 1.07
Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil. Clin Chem (2001) 1.06
Identification of residues essential for human paraoxonase (PON1) arylesterase/organophosphatase activities. Biochemistry (1999) 1.06
Surveillance of human Yersinia enterocolitica infections in Belgium: 1963-1978. J Infect (1982) 1.06
Use of the non-pneumatic anti-shock garment (NASG) to reduce blood loss and time to recovery from shock for women with obstetric haemorrhage in Egypt. Glob Public Health (2007) 1.06
The interaction between clarithromycin and cyclosporine in kidney transplant recipients. Transplantation (1994) 1.03
Outcome of patients with tuberous sclerosis after renal transplantation. Transplantation (1990) 1.02
Endocarditis of native aortic and mitral valves due to Corynebacterium accolens: report of a case and application of phenotypic and genotypic techniques for identification. J Clin Microbiol (1996) 1.02
Combined immunosuppressive therapy with cyclosporin A and azathioprine. A synergistic effect in three of four experimental models. Transplantation (1982) 1.01
Surveillance of human Yersinia enterocolitica infections in Belgium: 1967-1996. Clin Infect Dis (1998) 1.00
Severe human infections caused by Vibrio metschnikovii. J Clin Microbiol (1993) 1.00
Three cases of opportunistic infection caused by propionic acid producing Corynebacterium minutissimum. Eur J Clin Microbiol Infect Dis (1992) 0.99
Detection of pYV+ Yersinia enterocolitica isolates by P1 slide agglutination. J Clin Microbiol (1990) 0.99
Video-assisted neck exploration for primary and secondary hyperparathyroidism: initial experience. Surg Endosc (2001) 0.98
Correlation of serological and biochemical groupings of Yersinia enterocolitica with the beta-lactamases of the strains. J Gen Microbiol (1977) 0.98
Chronic osteomyelitis due to Actinomyces neuii subspecies neuii and Dermabacter hominis. Eur J Clin Microbiol Infect Dis (2002) 0.97
Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade. Xenotransplantation (2002) 0.96
Multiple spontaneous ruptures of tendons in renal transplant recipient. Br Med J (Clin Res Ed) (1984) 0.96
Septicemia due to Solobacterium moorei in a patient with multiple myeloma. Anaerobe (2006) 0.95
Analysis of clinical and environment Yersinia isolates in the Republic of Georgia. J Clin Microbiol (1996) 0.95
[Möbius syndrome: ocular and clinical manifestations]. J Fr Ophtalmol (2007) 0.94
Course of Henoch-Schönlein nephritis after renal transplantation. Report on ten patients and review of the literature. Transplantation (1994) 0.94
Increase of physical activity level after successful renal transplantation: a 5 year follow-up study. Nephrol Dial Transplant (2001) 0.94
The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations. Cancer (1995) 0.94
Urothelial malignancy in nephropathy due to Chinese herbs. Lancet (1994) 0.94
Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation. Clin Chem (2001) 0.94
Endoscope affects decision making in cholesteatoma surgery. Otolaryngol Head Neck Surg (2003) 0.93
Legionella spp. in a hospital hot water system: effect of control measures. J Hosp Infect (1989) 0.93
Pressure-induced molten globule state of cholinesterase. FEBS Lett (1995) 0.92
Human ABO-incompatible living donor renal homografts. Neth J Med (1985) 0.92
Corynebacterium simulans sp. nov., a non-lipophilic, fermentative Corynebacterium. Int J Syst Evol Microbiol (2000) 0.91
The influence of solvent composition on global dynamics of human butyrylcholinesterase powders: a neutron-scattering study. Biophys J (2004) 0.91
Identification of vancomycin-resistant lactic bacteria isolated from humans. J Clin Microbiol (1993) 0.90
Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors. Clin Nephrol (1998) 0.90
Bacteraemia caused by Leptotrichia trevisanii in a neutropenic patient. Anaerobe (2010) 0.90
Acute colonic complications after kidney transplantation. Acta Chir Belg (1995) 0.89
Enteritis, abscess and septicaemia by Yersinia enterocolitica in a thalassaemic child. Contrib Microbiol Immunol (1979) 0.89
Short-comings of irgasan ticarcillin chlorate broth for the enrichment of Yersinia enterocolitica biotype 2, serotype 9 from meat. Int J Food Microbiol (1994) 0.89
Direct phasing at low resolution of a protein copurified with human paraoxonase (PON1). Acta Crystallogr D Biol Crystallogr (2003) 0.89
Pancreas transplantation for treatment of generalized allergy to human insulin in type 1 diabetes. Transplant Proc (2005) 0.89
Isolation of Corynebacterium group D2 from clinical specimens. Eur J Clin Microbiol (1987) 0.89